The discovery of new immunosuppressive drugs has resulted in an improvement of short-term graft survival. Despite this achievement, long-term cardiac allograft survival has not been correspondingly improved. Cyclosporine A (CsA), an effective immunosuppressive drug, has been shown to increase the risk of hyperlipidemia, hypertension, kidney injuries and chronic rejection despite its extensive use in the clinical setting. Therefore, these side-effects of CsA, may further contribute to graft failure over long-term. Early studies have shown that fish oil may reduce side-effects of CsA. These beneficial effects of fish oil may be related to n-3 fatty acids (n-3 FAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Flaxseed oil is another major source of an n-3 FA, namely α-linolenic acid (ALA). However, its impact on heart transplantation has not been fully explored. The current study aimed to investigate whether dietary flaxseed oil and fish oil reduce post-transplant complications and prolong graft function in a rat cardiac allograft model. Male Fischer and Lewis rats were used as donors and recipients, respectively, to generate a heterotopic cardiac allograft model. After transplant, animals were randomly assigned into 3 groups and fed a diet supplemented with: a) 5% w/w safflower oil (control n=7), b) 5% w/w flaxseed oil (n=8) or c) 2% w/w fish oil (n=7) and an intraperitoneal injection of cyclosporine A (CsA) (1.5 mg/kg/d) over 12 weeks. Body weight, blood pressure (BP), plasma levels of lipids, CsA, and select cytokines, fatty acid profile of hearts (native and graft) and liver tissues as well as graft function and chronic rejection features were assessed. Body weight and blood CsA levels were similar among the groups. As compared to controls, both diet treated groups demonstrated a significantly lower systolic blood pressure (SBP) (p<0.001), diastolic blood pressure (pressure (DBP) (p<0.001), mean arterial pressure (MAP) (p<0.001), heart rate (p<0.05), abdominal fat (p<0.05) and plasma levels of macrophage chemoattractant protein-1 (MCP-1) (p<0.05). Moreover, the fish oil group had significantly (p<0.05) lower plasma levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL), as compared to the control group. High-density lipoprotein cholesterol (HDL) concentrations were significantly higher (P<0.05) in the flaxseed oil-treated group as compared to the other two groups. Data of this study suggest that both flaxseed oil and fish oil may provide similar biochemical, hemodynamic and inflammatory improvements after heart transplantation; however, these apparent beneficial changes were not accompanied with significant reductions in chronic rejection states or apparent histological evidence of cyclosporine-induced nephrotoxicity in this model.

The discovery of new immunosuppressive drugs has resulted in an improvement of short-term graft survival. Despite this achievement, long-term cardiac allograft survival has not been correspondingly improved. Cyclosporine A (CsA), an effective immunosuppressive drug, has been shown to increase the risk of hyperlipidemia, hypertension, kidney injuries and chronic rejection despite its extensive use in the clinical setting. Therefore, these side-effects of CsA, may further contribute to graft failure over long-term. Early studies have shown that fish oil may reduce side-effects of CsA. These beneficial effects of fish oil may be related to n-3 fatty acids (n-3 FAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Flaxseed oil is another major source of an n-3 FA, namely α-linolenic acid (ALA). However, its impact on heart transplantation has not been fully explored. The current study aimed to investigate whether dietary flaxseed oil and fish oil reduce post-transplant complications and prolong graft function in a rat cardiac allograft model. Male Fischer and Lewis rats were used as donors and recipients, respectively, to generate a heterotopic cardiac allograft model. After transplant, animals were randomly assigned into 3 groups and fed a diet supplemented with: a) 5% w/w safflower oil (control n=7), b) 5% w/w flaxseed oil (n=8) or c) 2% w/w fish oil (n=7) and an intraperitoneal injection of cyclosporine A (CsA) (1.5 mg/kg/d) over 12 weeks. Body weight, blood pressure (BP), plasma levels of lipids, CsA, and select cytokines, fatty acid profile of hearts (native and graft) and liver tissues as well as graft function and chronic rejection features were assessed. Body weight and blood CsA levels were similar among the groups. As compared to controls, both diet treated groups demonstrated a significantly lower systolic blood pressure (SBP) (p<0.001), diastolic blood pressure (pressure (DBP) (p<0.001), mean arterial pressure (MAP) (p<0.001), heart rate (p<0.05), abdominal fat (p<0.05) and plasma levels of macrophage chemoattractant protein-1 (MCP-1) (p<0.05). Moreover, the fish oil group had significantly (p<0.05) lower plasma levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL), as compared to the control group. High-density lipoprotein cholesterol (HDL) concentrations were significantly higher (P<0.05) in the flaxseed oil-treated group as compared to the other two groups. Data of this study suggest that both flaxseed oil and fish oil may provide similar biochemical, hemodynamic and inflammatory improvements after heart transplantation; however, these apparent beneficial changes were not accompanied with significant reductions in chronic rejection states or apparent histological evidence of cyclosporine-induced nephrotoxicity in this model.

No / Because of confounding factors, the effects of dietary n-3 polyunsaturated fatty acids (PUFA) on type 1 diabetes remain to be clarified. We therefore evaluated whether fat-1 transgenic mice, a well-controlled experimental model endogenously synthesizing n-3 PUFA, were protected against streptozotocin (STZ)-induced diabetes. We then aimed to elucidate the in vivo response at the pancreatic level. Beta-Cell destruction was produced by multiple low-doses STZ (MLD-STZ). Blood glucose level, plasma insulin level, and plasma lipid analysis were then performed. Pancreatic mRNA expression of cytokines, the monocyte chemoattractant protein, and GLUT2 were evaluated as well as pancreas nuclear factor (NF)-kB p65 and inhibitor of kB (IkB) protein expression. Insulin and cleaved caspase-3 immunostaining and lipidomic analysis were performed in the pancreas. STZ-induced fat-1 mice did not develop hyperglycemia compared with wild-type mice, and Beta-cell destruction was prevented as evidenced by lack of histological pancreatic damage or reduced insulin level. The prevention of Beta-cell destruction was associated with no proinflammatory cytokine induction (tumor necrosis factor-alpha, interleukin-1Beta, inducible nitric oxide synthase) in the pancreas, a decreased NF-kB, and increased IkB pancreatic protein expression. In the fat-1-treated mice, proinflammatory arachidonic-derived mediators as prostaglandin E2 and 12-hydroxyeicosatetraenoic acid were decreased and the anti-inflammatory lipoxin A4 was detected. Moreover, the 18-hydroxyeicosapentaenoic acid, precursor of the anti-inflammatory resolvin E1, was highly increased. Collectively, these findings indicate that fat-1 mice were protected against MLD-STZ-induced diabetes and pointed out for the first time in vivo the beneficial effects of n-3 PUFA at the pancreatic level, on each step of the development of the pathology-inflammation, Beta-cell damage-through cytokine response and lipid mediator production.

Many populations have low intakes of n-3 fatty acids, yet there is substantial evidence that the long chain n-3 fatty acid docosahexaenoic acid (DHA; 22:6n-3), found at high concentrations in the brain, is required for the proper development of the nervous system. However, less is known about requirements of long chain n-3 fatty acids for maintenance and function of the nervous system in later life. Several recent studies have reported that high amounts of long chain n-3 fatty acids reduce the extent of brain damage caused by cerebral ischemia in animals. However, whether or not a dietary deficiency of n-3 fatty acids increases the extent of injury when cerebral ischemia occurs has not been previously reported. The present studies, therefore, sought to determine if a diet deficient in n-3 fatty acids influences the extent of brain injury in the rat following cerebral ischemia. Male rats were fed an n-3 fatty acid adequate (control), an n-3 fatty acid deficient, or a high DHA diet for 5 weeks from weaning. Middle cerebral artery occlusion (MCAO) was induced and infarct volume was measured by 2,3,5,-triphenyltetrazolium chloride staining 24 hours after the procedure. Brain and platelet fatty acids were analyzed by gas liquid chromatography. DHA (22:6n-3) was 21-28% lower in brain phospholipids, and 17% lower in brain total fatty acids in the n-3 fatty acid deficient compared to control group, while 22:6n-3 was 12% higher in total brain fatty acids in the high DHA group than the control group. There was no significant difference in infarct volume (203, 220 and 218 mm³) among the control, n-3 fatty acid deficient, and high DHA groups, respectively. Platelet fatty acids and platelet aggregation were assessed to determine if these were influenced by the high DHA diet, and could possibly explain the observation of an apparent, but not statistically significant, higher number of rats with hemorrhages in the high DHA diet group. Platelet lipid arachidonic acid was not lower and platelet aggregation, assessed ex vivo using whole blood with a platelet function analyzer, was not longer in rats fed the high DHA compared to control or n-3 fatty acid deficient diets. In summary, dietary n-3 fatty acid deficiency did not increase the extent of brain injury following cerebral ischemia. The possibility that high dietary 22:6n-3 might increase susceptibility to cerebral hemorrhage will require further study.

T helper (Th) cell activation is necessary for the adaptive immune response. Formation of an immunological synapse (IS) between Th cells and antigen-presenting cells is the first step in Th cell activation. In vitro studies indicate that formation of the IS induces cytoskeleton-dependent mitochondrial redistribution to the immediate vicinity of the IS. This redistribution of mitochondria to the IS in T cells is necessary to maintain Ca2 influx across the plasma membrane and Ca2 -dependent Th cell activation. Earlier studies have demonstrated that n-3 polyunsaturated fatty acids (PUFA) suppress the localization and activation of signaling proteins at the IS. Therefore, we hypothesized that n-3 PUFA suppress CD4 T cell mitochondrial translocation during the early stages of IS formation and down-modulate Ca2 dependent Th cell activation. CD4 cells derived from fat-1 mice, a transgenic model that synthesizes n-3 PUFA from n-6 PUFA, were co-cultured with anti-CD3-expressing hybridoma cells (145-2C11) for 15 min at 37 degrees C, and mitochondrial translocation to the IS was assessed by confocal microscopy. fat-1 mice exhibited a significantly (P< 0.05) reduced percentage of CD4 T cells with mitochondria which translocated to the IS; fat-1 (30 percent) versus wild type control (82 percent). With respect to an effect on the mitochondrial-to-cytosolic Ca2 ratio, wild type cells showed significant increases at the IS (71 percent) and total cell (60 percent) within 30 min of IS formation. In contrast, fat-1 CD4 T cells remained at basal levels following the IS formation. A similar blunting of the mitochondrial-to-cytosolic Ca2 ratio was observed in wild type cells co-incubated with inhibitors of the mitochondrial uniporter, RU360 or calcium release-activated Ca2 (CRAC) channels, BTP2. Together, these observations provide evidence that n-3 PUFA modulate Th cell activation by limiting mitochondrial translocation to the IS and reducing Ca2 entry.

Many populations have low intakes of n-3 fatty acids, yet there is substantial evidence that the long chain n-3 fatty acid docosahexaenoic acid (DHA; 22:6n-3), found at high concentrations in the brain, is required for the proper development of the nervous system. However, less is known about requirements of long chain n-3 fatty acids for maintenance and function of the nervous system in later life. Several recent studies have reported that high amounts of long chain n-3 fatty acids reduce the extent of brain damage caused by cerebral ischemia in animals. However, whether or not a dietary deficiency of n-3 fatty acids increases the extent of injury when cerebral ischemia occurs has not been previously reported. The present studies, therefore, sought to determine if a diet deficient in n-3 fatty acids influences the extent of brain injury in the rat following cerebral ischemia. Male rats were fed an n-3 fatty acid adequate (control), an n-3 fatty acid deficient, or a high DHA diet for 5 weeks from weaning. Middle cerebral artery occlusion (MCAO) was induced and infarct volume was measured by 2,3,5,-triphenyltetrazolium chloride staining 24 hours after the procedure. Brain and platelet fatty acids were analyzed by gas liquid chromatography. DHA (22:6n-3) was 21-28% lower in brain phospholipids, and 17% lower in brain total fatty acids in the n-3 fatty acid deficient compared to control group, while 22:6n-3 was 12% higher in total brain fatty acids in the high DHA group than the control group. There was no significant difference in infarct volume (203, 220 and 218 mm³) among the control, n-3 fatty acid deficient, and high DHA groups, respectively. Platelet fatty acids and platelet aggregation were assessed to determine if these were influenced by the high DHA diet, and could possibly explain the observation of an apparent, but not statistically significant, higher number of rats with hemorrhages in the high DHA diet group. Platelet lipid arachidonic acid was not lower and platelet aggregation, assessed ex vivo using whole blood with a platelet function analyzer, was not longer in rats fed the high DHA compared to control or n-3 fatty acid deficient diets. In summary, dietary n-3 fatty acid deficiency did not increase the extent of brain injury following cerebral ischemia. The possibility that high dietary 22:6n-3 might increase susceptibility to cerebral hemorrhage will require further study.

Many populations have low intakes of n-3 fatty acids, yet there is substantial evidence that the long chain n-3 fatty acid docosahexaenoic acid (DHA; 22:6n-3), found at high concentrations in the brain, is required for the proper development of the nervous system. However, less is known about requirements of long chain n-3 fatty acids for maintenance and function of the nervous system in later life. Several recent studies have reported that high amounts of long chain n-3 fatty acids reduce the extent of brain damage caused by cerebral ischemia in animals. However, whether or not a dietary deficiency of n-3 fatty acids increases the extent of injury when cerebral ischemia occurs has not been previously reported. The present studies, therefore, sought to determine if a diet deficient in n-3 fatty acids influences the extent of brain injury in the rat following cerebral ischemia. Male rats were fed an n-3 fatty acid adequate (control), an n-3 fatty acid deficient, or a high DHA diet for 5 weeks from weaning. Middle cerebral artery occlusion (MCAO) was induced and infarct volume was measured by 2,3,5,-triphenyltetrazolium chloride staining 24 hours after the procedure. Brain and platelet fatty acids were analyzed by gas liquid chromatography. DHA (22:6n-3) was 21-28% lower in brain phospholipids, and 17% lower in brain total fatty acids in the n-3 fatty acid deficient compared to control group, while 22:6n-3 was 12% higher in total brain fatty acids in the high DHA group than the control group. There was no significant difference in infarct volume (203, 220 and 218 mm³) among the control, n-3 fatty acid deficient, and high DHA groups, respectively. Platelet fatty acids and platelet aggregation were assessed to determine if these were influenced by the high DHA diet, and could possibly explain the observation of an apparent, but not statistically significant, higher number of rats with hemorrhages in the high DHA diet group. Platelet lipid arachidonic acid was not lower and platelet aggregation, assessed ex vivo using whole blood with a platelet function analyzer, was not longer in rats fed the high DHA compared to control or n-3 fatty acid deficient diets. In summary, dietary n-3 fatty acid deficiency did not increase the extent of brain injury following cerebral ischemia. The possibility that high dietary 22:6n-3 might increase susceptibility to cerebral hemorrhage will require further study. / Medicine, Faculty of / Pathology and Laboratory Medicine, Department of / Graduate

Consumer awareness of the link between dietary fats and health outcomes has led to increased demand for food products enriched with bioactive fatty acids (FA). Ruminant-derived fats, such as dairy fats, contribute significantly to the American diet and contain many unique beneficial FA, such as short- and medium-chain FA, n-3 FA, conjugated linoleic acids (CLA), vaccenic acid (VA), as well as odd-and branched-chain FA (OBCFA). Increasing these FA in dairy products by altering farm management practices, such as breed, lactation stage, and nutrition, may improve human health without a change to the diet. The overarching goal of this dissertation was to evaluate on-farm strategies to increase the content of bioactive FA in bovine milk. The first objective was to enrich milk fat with bioactive FA via supplementation with echium oil, a terrestrial oil rich in n-3 FA. Treatments were 1.5% and 3.0% dry matter as lipid encapsulated echium oil (EEO) which were compared to a control (no EEO). Milk fat contents of n-3 FA increased with EEO supplementation but the transfer of n-3 FA from EEO into milk fat was rather low (< 5%). In a subsequent trial, ruminal protection of EEO and post-ruminal release of EEO-derived FA was examined. EEO-derived FA were preferentially incorporated into plasma lipid fractions unavailable to the mammary gland. Moreover, fecal excretion of EEO-derived FA ranged from 7-14% of intake, and VA and CLA, the biohydrogenation and metabolism products of n-3 FA, increased in milk and feces with EEO supplementation. Therefore, lipid-encapsulation provided inadequate digestibility and low transfer efficiency of n-3 FA into milk. The second objective was to compare the bacterial community structure and unique bioactive FA in bacterial membranes and milk fat between Holstein (HO), Jersey (JE), and HO x JE crossbreeds (CB) across a lactation. Lactation stage had a prominent effect on rumen bacterial taxa, with Firmicutes being most abundant during early lactation. The FA composition of bacterial cells was affected by both lactation stage and genetics, and OBCFA in bacterial cells were positively correlated with several bacteria of the Firmicutes phylum. HO and CB exhibited greater contents of various bioactive FA in milk than JE. The highest content of all bioactive FA occurred at early lactation, while OBCFA were highest at late lactation. The third objective was to determine the effects of grazing a monoculture vs. a diverse pasture on rumen bacterial and protozoal taxa, their membrane FA composition, and milk FA. Microbial communities shifted in response to grazing regime accompanied with changes in their membrane FA profiles. Rumen microbiota from cows grazing a diverse pasture had higher contents of n-3 FA and VA, but lower contents of OBCFA. Microbial membrane FA correlated with microbial taxa, the contents of ALA and n-3 FA were positively correlated with the bacterial genus Butyrivibrio and the protozoal genus Eudioplodinium. Milk contents of CLA and n-3 FA increased when cows grazed a diverse pasture, while grazing a monoculture led to greater milk contents of OBCFA. In conclusion, grazing cows on a diverse pasture, when compared to genetic effects and lipid supplementation, was the most efficacious strategy to increase the content of bioactive FA in milk.

O exercício físico intenso está associado à mudanças na quantidade, na função e na morte de neutrófilos. Tem sido proposto que a suplementação com óleo de peixe minimiza os efeitos imunossupressivos do exercício físico e que a fosfatidilcolina também poderia exercer importantes efeitos sobre a função de leucócitos. O objetivo do estudo foi o de investigar os efeitos da meia maratona e da suplementação com lecitina de soja ou óleos de peixe ricos em EPA ou DHA na apoptose de neutrófilos de atletas amadores. Quarenta e seis atletas amadores, foram avaliados antes e após duas competições de meia maratona. Na primeira meia maratona, os atletas não foram suplementados. As coletas de sangue dos atletas foram realizadas nas seguintes condições: Em repouso e imediatamente após a competição. No primeiro dia, após a primeira meia maratona, iniciou-se a suplementação. Os indivíduos foram suplementados diariamente com 3g de óleo de peixe ou lecitina de soja, por 60 dias, e divididos em 3 grupos: 1) Lecitina, 2) DHA e 3) EPA. Os atletas foram reavaliados 8 semanas após o início da suplementação. Já na segunda meia maratona, com todos os atletas suplementados, as coletas de sangue foram realizadas nas mesmas condições da primeira corrida. Neste estudo avaliamos os receptores da apoptose de neutrófilos (Fas e TRAIL), as moléculas de adesão (L-selectina e ICAM-1), a fragmentação de DNA e a externalização de fosfatidilserina. Além disso, foi avaliada a concentração plasmática das citocinas TNF-alfa, IL-8, IL-6, IL-4, IL-10 e IL-1beta. As enzimas creatina quinase e lactato desidrogenase, a concentração de mioglobina, proteína C reativa e o número de leucócitos e neutrófilos também foi determinada. A meia maratona aumentou a atividade das enzimas CK e LDH e a concentração de mioglobina em todos os grupos estudados, sendo que a suplementação não apresentou nenhum efeito sobre estes parâmetros. Já o número de neutrófilos e leucócitos, aumentaram após a meia maratona em todos os grupos, e a suplementação provocou este aumento somente nos grupos EPA e Lecitina. Em neutrófilos de atletas, a meia maratona diminuiu a expressão dos receptores Fas e TRAIL e das móleculas de adesão ICAM-1 e L-selectina em todos os grupos, por outro lado, aumentou a fragmentação de DNA (somente no grupo DHA) e a externalização de FS (DHA, EPA e Lectina). A meia maratona também elevou a concentração das citocinas IL-8, IL-6 e IL-10 em todos os grupos. Já a suplementação (DHA, EPA ou lecitina de soja) diminuiu a fragmentação de DNA e a expressão do receptor Fas em neutrófilos. Além disso, aumentou a expressão de TRAIL, ICAM-1, L-selectina e a externalização de fosfatidilserina. Em relação a concentração plasmática de citocinas a suplementação reduziu a concentração de TNF-alfa e aumentou a de IL-10 em todos os grupos. Enquanto que, a concentração de IL-4 aumentou somente nos grupos DHA e EPA. Concluímos que a suplementação com lecitina de soja apresenta efeitos semelhantes aos dos óleos de peixe ricos em EPA ou DHA sobre a função de leucócitos em atletas amadores. / Intense physical exercise is associated with changes in the number, function and death of neutrophils. It has been proposed that supplementation with fish oil rich minimizes the immunosuppressive effects induced by intense physical exercise and phosphatidylcholine could also have significant effects on leukocytes function. The aim of this study was to investigate the effects of a half-marathon and fish oil suplemmentation rich in EPA or DHA or soy lecithin suplemmentation on neutrophils apoptosis of amateur athletes. Forty-six recreational athletes were evaluated before and after two half marathons. In the first competition the athletes did not receive supplementation. Blood samples were collected in the following conditions: In rest and immediately after competition. On the first day, after the first half-marathon, supplementation began. The subjects were supplemented with 3 g of fish oil or soy lecithin daily for 60 days and divided into 3 groups: 1) Lecithin 2) DHA 3) EPA. The athletes were assessed 8 weeks after the start of supplementation. In the second half-marathon, with all the supplemented athletes, blood samples were collected under the same conditions of the first competition. In this study were evaluated the receptors of neutrophils apoptosis (Fas and TRAIL), adhesion molecules (L-selectin and ICAM-1), DNA fragmentation and phosphatidylserine externalization. Moreover, the plasma concentration of TNF-alpha, IL-8, IL-6, IL-4, IL-10 and IL-1beta cytokines was evaluated. The enzymatic activity of creatine kinase and lactate dehydrogenase, plasma concentration of myoglobin, and C-reactive protein and blood counts was also determined. The half-marathon increased the enzymatic activity of CK and LDH and the myoglobin concentration in all groups studied, and the supplementation had no effect on these parameters. The number of neutrophils and leucocytes increased in all groups after half marathon, and the supplementation caused this increase only in the EPA and Lecithin groups. In athletes neutrophils, the half-marathon decreased the expression of Fas and TRAIL receptors and of ICAM-1 and L-selectin adhesion molecules. On the other hand, it increased DNA fragmentation (only in the DHA group) and phosphatidylserine externalization (DHA, EPA and Lecithin groups). The half-marathon also increased concentrations of IL-8, IL-6 and IL-10 cytokines in all groups. The Supplementation (DHA or EPA or soy lecithin) decreased DNA fragmentation and Fas receptor expression in neutrophils. Moreover, increased expression of TRAIL, ICAM-1, L-selectin and phosphatidylserine externalization. In relation to cytokines plasma concentration the supplementation decreased TNF-alfa and increased the concentration of IL-10 in all groups. Whereas, IL-4 concentration increased only DHA and EPA groups. In conclusion, supplementation with soy lecithin has similar effects to the fish oils rich in EPA or DHA on leukocyte function amateur athletes.

O exercício físico intenso está associado à mudanças na quantidade, na função e na morte de neutrófilos. Tem sido proposto que a suplementação com óleo de peixe minimiza os efeitos imunossupressivos do exercício físico e que a fosfatidilcolina também poderia exercer importantes efeitos sobre a função de leucócitos. O objetivo do estudo foi o de investigar os efeitos da meia maratona e da suplementação com lecitina de soja ou óleos de peixe ricos em EPA ou DHA na apoptose de neutrófilos de atletas amadores. Quarenta e seis atletas amadores, foram avaliados antes e após duas competições de meia maratona. Na primeira meia maratona, os atletas não foram suplementados. As coletas de sangue dos atletas foram realizadas nas seguintes condições: Em repouso e imediatamente após a competição. No primeiro dia, após a primeira meia maratona, iniciou-se a suplementação. Os indivíduos foram suplementados diariamente com 3g de óleo de peixe ou lecitina de soja, por 60 dias, e divididos em 3 grupos: 1) Lecitina, 2) DHA e 3) EPA. Os atletas foram reavaliados 8 semanas após o início da suplementação. Já na segunda meia maratona, com todos os atletas suplementados, as coletas de sangue foram realizadas nas mesmas condições da primeira corrida. Neste estudo avaliamos os receptores da apoptose de neutrófilos (Fas e TRAIL), as moléculas de adesão (L-selectina e ICAM-1), a fragmentação de DNA e a externalização de fosfatidilserina. Além disso, foi avaliada a concentração plasmática das citocinas TNF-alfa, IL-8, IL-6, IL-4, IL-10 e IL-1beta. As enzimas creatina quinase e lactato desidrogenase, a concentração de mioglobina, proteína C reativa e o número de leucócitos e neutrófilos também foi determinada. A meia maratona aumentou a atividade das enzimas CK e LDH e a concentração de mioglobina em todos os grupos estudados, sendo que a suplementação não apresentou nenhum efeito sobre estes parâmetros. Já o número de neutrófilos e leucócitos, aumentaram após a meia maratona em todos os grupos, e a suplementação provocou este aumento somente nos grupos EPA e Lecitina. Em neutrófilos de atletas, a meia maratona diminuiu a expressão dos receptores Fas e TRAIL e das móleculas de adesão ICAM-1 e L-selectina em todos os grupos, por outro lado, aumentou a fragmentação de DNA (somente no grupo DHA) e a externalização de FS (DHA, EPA e Lectina). A meia maratona também elevou a concentração das citocinas IL-8, IL-6 e IL-10 em todos os grupos. Já a suplementação (DHA, EPA ou lecitina de soja) diminuiu a fragmentação de DNA e a expressão do receptor Fas em neutrófilos. Além disso, aumentou a expressão de TRAIL, ICAM-1, L-selectina e a externalização de fosfatidilserina. Em relação a concentração plasmática de citocinas a suplementação reduziu a concentração de TNF-alfa e aumentou a de IL-10 em todos os grupos. Enquanto que, a concentração de IL-4 aumentou somente nos grupos DHA e EPA. Concluímos que a suplementação com lecitina de soja apresenta efeitos semelhantes aos dos óleos de peixe ricos em EPA ou DHA sobre a função de leucócitos em atletas amadores. / Intense physical exercise is associated with changes in the number, function and death of neutrophils. It has been proposed that supplementation with fish oil rich minimizes the immunosuppressive effects induced by intense physical exercise and phosphatidylcholine could also have significant effects on leukocytes function. The aim of this study was to investigate the effects of a half-marathon and fish oil suplemmentation rich in EPA or DHA or soy lecithin suplemmentation on neutrophils apoptosis of amateur athletes. Forty-six recreational athletes were evaluated before and after two half marathons. In the first competition the athletes did not receive supplementation. Blood samples were collected in the following conditions: In rest and immediately after competition. On the first day, after the first half-marathon, supplementation began. The subjects were supplemented with 3 g of fish oil or soy lecithin daily for 60 days and divided into 3 groups: 1) Lecithin 2) DHA 3) EPA. The athletes were assessed 8 weeks after the start of supplementation. In the second half-marathon, with all the supplemented athletes, blood samples were collected under the same conditions of the first competition. In this study were evaluated the receptors of neutrophils apoptosis (Fas and TRAIL), adhesion molecules (L-selectin and ICAM-1), DNA fragmentation and phosphatidylserine externalization. Moreover, the plasma concentration of TNF-alpha, IL-8, IL-6, IL-4, IL-10 and IL-1beta cytokines was evaluated. The enzymatic activity of creatine kinase and lactate dehydrogenase, plasma concentration of myoglobin, and C-reactive protein and blood counts was also determined. The half-marathon increased the enzymatic activity of CK and LDH and the myoglobin concentration in all groups studied, and the supplementation had no effect on these parameters. The number of neutrophils and leucocytes increased in all groups after half marathon, and the supplementation caused this increase only in the EPA and Lecithin groups. In athletes neutrophils, the half-marathon decreased the expression of Fas and TRAIL receptors and of ICAM-1 and L-selectin adhesion molecules. On the other hand, it increased DNA fragmentation (only in the DHA group) and phosphatidylserine externalization (DHA, EPA and Lecithin groups). The half-marathon also increased concentrations of IL-8, IL-6 and IL-10 cytokines in all groups. The Supplementation (DHA or EPA or soy lecithin) decreased DNA fragmentation and Fas receptor expression in neutrophils. Moreover, increased expression of TRAIL, ICAM-1, L-selectin and phosphatidylserine externalization. In relation to cytokines plasma concentration the supplementation decreased TNF-alfa and increased the concentration of IL-10 in all groups. Whereas, IL-4 concentration increased only DHA and EPA groups. In conclusion, supplementation with soy lecithin has similar effects to the fish oils rich in EPA or DHA on leukocyte function amateur athletes.